EW

Edwards Lifesciences
D

EW

Arincen78/100B

Edwards Lifesciences free cash flow 1999–2026

Edwards Lifesciences's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 506.70M USD, down 1.8% on the same quarter a year before. Edwards Lifesciences's free cash flow over the last twelve months was 1.42B USD, up 77.1% on the twelve months before. In fiscal year 2025 it was 1.34B USD, up 360.5% on the year before.

Last updated 10 Nov 2026 · Next report 9 Feb 2027

Free cash flow

Free cash flow · +11.7% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20261.42B+77.08%21.34%1.72B-292.80M2.46
FY202531 Dec 20251.34B+360.50%22.00%1.60B-260.20M2.28
FY202431 Dec 2024289.90M-53.95%5.33%542.30M-252.40M0.48
FY202331 Dec 2023629.50M-33.97%12.56%895.80M-266.30M1.03
FY202231 Dec 2022953.40M-32.01%17.71%1.22B-264.80M1.53
FY202131 Dec 20211.40B+116.74%26.80%1.73B-329.80M2.22
FY202031 Dec 2020647.00M-28.19%14.75%1.05B-407.30M1.02
FY201931 Dec 2019901.00M+31.51%20.72%1.18B-278.40M1.42
FY201831 Dec 2018685.10M-16.98%18.40%926.80M-241.70M1.07
FY201731 Dec 2017825.20M+69.45%24.02%1.00B-175.50M1.27
FY201631 Dec 2016487.00M+9.88%16.43%704.40M-217.40M0.75
FY201531 Dec 2015443.20M-52.27%17.77%549.70M-106.50M0.67
FY201431 Dec 2014928.60M+156.09%39.98%1.02B-93.70M1.43
FY201331 Dec 2013362.60M+47.34%17.73%472.70M-110.10M0.53
FY201231 Dec 2012246.10M+9.92%12.96%373.80M-127.70M0.35
FY201131 Dec 2011223.90M+18.84%13.34%314.50M-90.60M0.31
FY201031 Dec 2010188.40M+85.98%13.02%251.40M-63.00M0.26
FY200931 Dec 2009101.30M+34.71%7.67%165.30M-64.00M0.14
FY200831 Dec 200875.20M-49.09%6.08%153.20M-78.00M0.11
FY200731 Dec 2007147.70M-13.83%13.54%210.20M-62.50M0.20
FY200631 Dec 2006171.40M+94.11%16.53%230.80M-59.40M0.22
FY200531 Dec 200588.30M-36.06%8.85%136.80M-48.50M0.12
FY200431 Dec 2004138.10M+63.63%14.83%180.60M-42.50M0.19
FY200331 Dec 200384.40M+5.63%9.81%122.30M-37.90M0.12
FY200231 Dec 200279.90M+26.83%11.35%120.60M-40.70M0.11
FY200131 Dec 200163.00M-30.77%9.10%101.00M-38.00M0.09
FY200031 Dec 200091.00M-32.09%11.32%137.00M-46.00M0.13
FY199931 Dec 1999134.00M—14.81%176.00M-42.00M0.19

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Edwards Lifesciences's free cash flow

Source: Financial Modeling Prep